lead position
Sponsored content
Sponsored by
CAS
Join Managing IP and CAS on December 11 for a practical discussion on why critical references are still missed in intellectual property searches, and how strategic search design can reduce risk and improve outcomes
November 10, 2025
Features list
-
Trade mark owners need to weigh up various factors when deciding where to bring an infringement action. Sahira Khwaja, Alastair Shaw, Leopold von Gerlach, Ewa Kacperek, Marie-Aimée de Dampierre and Alexis Valot compare procedures and practices in France, Germany, Poland and the United Kingdom
-
Six years after its second edition of the WIPO Overview of WIPO Panel Views on Selected UDRP Questions, WIPO unveiled the third edition of its overview of UDRP jurisprudence. Justin Chay and Brian Beckham highlight several key updates
-
Tim Moss took over as chief executive of the UK IPO on May 1. Three months on, he talked to James Nurton about his ambitions, Brexit and being an “honest broker”
-
Practitioners have welcomed Intellectual Property Office of Singapore (IPOS) amendments to the patent regime to spur innovation and improve the quality of patents granted -
Brazil’s new Civil Procedure Code came into force last year. Breno Akherman and André Oliveira of Daniel Legal & IP Strategy analyse its impact on IP litigation so far
-
Clarity is needed on certain aspects of the law regarding patent claim amendment, argues Víctor Garrido of Dumont Bergman Bider & Co, SC
Local Insights
Sponsored by
Shiga International Patent Office
Masato Iida of Shiga International Patent Office says the decision by the Grand Panel of the Intellectual Property High Court provides a practical benchmark for calculating damages in cosmetic and medical patent infringement cases
Sponsored by
Berken IP
María Aurora García of Berken IP explains how Argentina’s evolving non-use cancellation system strengthens trademark integrity, streamlines registration, and promotes fairer market competition through efficient, partial, and administrative cancellation mechanisms
Sponsored by
Licks Attorneys
How UK extraterritorial decisions are undermining Brazilian judicial sovereignty and violating TRIPS
Senior patent attorneys at Licks Attorneys say recent UK court decisions on FRAND licensing conflict with Brazilian judicial sovereignty and the TRIPS framework governing the territorial independence of patents
Sponsored by
Gün and Partners
Selin Sinem Erciyas of Gün + Partners explores the growing alignment between Turkish courts and the Unified Patent Court in applying a strictly technical-functional standard for patent infringement by equivalence
Sponsored by
Liu, Shen & Associates
Wenjing Zhu of Liu, Shen & Associates explains how China’s administrative adjudication system is reshaping patent enforcement, offering faster, cost-effective, and technically expert resolutions for patentees, while preserving rights to pursue court remedies
Sponsored by
Wanhuida Intellectual Property
Minnan (Miranda) Xie of Wanhuida Intellectual Property analyses how China’s patent authorities and courts assess second medical use inventions, with key CNIPA decisions clarifying the treatment of dosage regimens and patient subgroups in novelty determinations
Sponsored by
Inventa
Vítor Palmela Fidalgo of Inventa examines how Portuguese case law diverges from EU rules on acquired distinctiveness, highlighting the Pão de Rio Maior decision and its implications for trademark interpretation and consumer protection
Sponsored by
Tilleke & Gibbins
Vietnam’s boom in AI-generated songs raises fundamental copyright questions, say Linh Duy Mai and Diep Thi Bich Le of T&G Law Firm LLC (TGVN), the local associate of Tilleke & Gibbins
Sponsored by
Hanol IP & Law
Min Son of Hanol IP & Law explains why the ruling by South Korea’s Intellectual Property High Court marks a key development in online patent enforcement
Sponsored by
Becerril, Coca & Becerril
Carlos Hernández León of Becerril, Coca & Becerril outlines how Mexico’s shift from NAFTA-based patent term extensions to the new SPC regime affects patent holders , particularly in pharmaceuticals, and the strategic steps to secure additional protection